Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001179354 | SCV001344002 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-10-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001401008 | SCV001602819 | likely benign | Ehlers-Danlos syndrome, type 4 | 2024-11-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001179354 | SCV002701071 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-03-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001401008 | SCV004832435 | likely benign | Ehlers-Danlos syndrome, type 4 | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004782589 | SCV005394419 | likely benign | not specified | 2024-09-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004541740 | SCV004795072 | likely benign | COL3A1-related disorder | 2019-03-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |